490 related articles for article (PubMed ID: 24056537)
1. Thalamic cholinergic innervation and postural sensory integration function in Parkinson's disease.
Müller ML; Albin RL; Kotagal V; Koeppe RA; Scott PJ; Frey KA; Bohnen NI
Brain; 2013 Nov; 136(Pt 11):3282-9. PubMed ID: 24056537
[TBL] [Abstract][Full Text] [Related]
2. Risky driving and pedunculopontine nucleus-thalamic cholinergic denervation in Parkinson disease.
Weathers SP; Kotagal V; Bohnen NI; Chou KL
Parkinsonism Relat Disord; 2014 Jan; 20(1):13-6. PubMed ID: 24070538
[TBL] [Abstract][Full Text] [Related]
3. History of falls in Parkinson disease is associated with reduced cholinergic activity.
Bohnen NI; Müller ML; Koeppe RA; Studenski SA; Kilbourn MA; Frey KA; Albin RL
Neurology; 2009 Nov; 73(20):1670-6. PubMed ID: 19917989
[TBL] [Abstract][Full Text] [Related]
4. Cholinergic system correlates of postural control changes in Parkinson's disease freezers.
Roytman S; Paalanen R; Griggs A; David S; Pongmala C; Koeppe RA; Scott PJH; Marusic U; Kanel P; Bohnen NI
Brain; 2023 Aug; 146(8):3243-3257. PubMed ID: 37086478
[TBL] [Abstract][Full Text] [Related]
5. Thalamic cholinergic innervation is spared in Alzheimer disease compared to parkinsonian disorders.
Kotagal V; Müller ML; Kaufer DI; Koeppe RA; Bohnen NI
Neurosci Lett; 2012 Apr; 514(2):169-72. PubMed ID: 22414859
[TBL] [Abstract][Full Text] [Related]
6. The cortical cholinergic system contributes to the top-down control of distraction: Evidence from patients with Parkinson's disease.
Kim K; Müller MLTM; Bohnen NI; Sarter M; Lustig C
Neuroimage; 2019 Apr; 190():107-117. PubMed ID: 29277400
[TBL] [Abstract][Full Text] [Related]
7. Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson's disease.
Bohnen NI; Müller ML; Kotagal V; Koeppe RA; Kilbourn MA; Albin RL; Frey KA
Brain; 2010 Jun; 133(Pt 6):1747-54. PubMed ID: 20413575
[TBL] [Abstract][Full Text] [Related]
8. Leucoaraiosis, nigrostriatal denervation and motor symptoms in Parkinson's disease.
Bohnen NI; Müller ML; Zarzhevsky N; Koeppe RA; Bogan CW; Kilbourn MR; Frey KA; Albin RL
Brain; 2011 Aug; 134(Pt 8):2358-65. PubMed ID: 21653540
[TBL] [Abstract][Full Text] [Related]
9. Balance control systems in Parkinson's disease and the impact of pedunculopontine area stimulation.
Perera T; Tan JL; Cole MH; Yohanandan SAC; Silberstein P; Cook R; Peppard R; Aziz T; Coyne T; Brown P; Silburn PA; Thevathasan W
Brain; 2018 Oct; 141(10):3009-3022. PubMed ID: 30165427
[TBL] [Abstract][Full Text] [Related]
10. Cholinergic brain network deficits associated with vestibular sensory conflict deficits in Parkinson's disease: correlation with postural and gait deficits.
Bohnen NI; Kanel P; Roytman S; Scott PJH; Koeppe RA; Albin RL; Kerber KA; Müller MLTM
J Neural Transm (Vienna); 2022 Aug; 129(8):1001-1009. PubMed ID: 35753016
[TBL] [Abstract][Full Text] [Related]
11. Symptoms of rapid eye movement sleep behavior disorder are associated with cholinergic denervation in Parkinson disease.
Kotagal V; Albin RL; Müller ML; Koeppe RA; Chervin RD; Frey KA; Bohnen NI
Ann Neurol; 2012 Apr; 71(4):560-8. PubMed ID: 22522445
[TBL] [Abstract][Full Text] [Related]
12. Gender differences in cholinergic and dopaminergic deficits in Parkinson disease.
Kotagal V; Albin RL; Müller ML; Koeppe RA; Frey KA; Bohnen NI
J Neural Transm (Vienna); 2013 Oct; 120(10):1421-4. PubMed ID: 23532360
[TBL] [Abstract][Full Text] [Related]
13. Association of Posture Instability with Dopamine Drop of Nigrostriatal System and Hypometabolism of Cerebral Cortex in Parkinson's Disease.
Wang H; Li HY; Guo X; Zhou Y
Curr Neurovasc Res; 2021; 18(2):244-253. PubMed ID: 34082681
[TBL] [Abstract][Full Text] [Related]
14. Frequency of cholinergic and caudate nucleus dopaminergic deficits across the predemented cognitive spectrum of Parkinson disease and evidence of interaction effects.
Bohnen NI; Albin RL; Müller ML; Petrou M; Kotagal V; Koeppe RA; Scott PJ; Frey KA
JAMA Neurol; 2015 Feb; 72(2):194-200. PubMed ID: 25506674
[TBL] [Abstract][Full Text] [Related]
15. In vivo imaging of neuromelanin in Parkinson's disease using 18F-AV-1451 PET.
Hansen AK; Knudsen K; Lillethorup TP; Landau AM; Parbo P; Fedorova T; Audrain H; Bender D; Østergaard K; Brooks DJ; Borghammer P
Brain; 2016 Jul; 139(Pt 7):2039-49. PubMed ID: 27190023
[TBL] [Abstract][Full Text] [Related]
16. Decreased vestibular efficacy contributes to abnormal balance in Parkinson's disease.
Bohnen NI; Roytman S; Griggs A; David SM; Beaulieu ML; Müller MLTM
J Neurol Sci; 2022 Sep; 440():120357. PubMed ID: 35932698
[TBL] [Abstract][Full Text] [Related]
17. Extra-nigral pathological conditions are common in Parkinson's disease with freezing of gait: an in vivo positron emission tomography study.
Bohnen NI; Frey KA; Studenski S; Kotagal V; Koeppe RA; Constantine GM; Scott PJ; Albin RL; Müller ML
Mov Disord; 2014 Aug; 29(9):1118-24. PubMed ID: 24909584
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity of cholinergic denervation in Parkinson's disease without dementia.
Bohnen NI; Müller ML; Kotagal V; Koeppe RA; Kilbourn MR; Gilman S; Albin RL; Frey KA
J Cereb Blood Flow Metab; 2012 Aug; 32(8):1609-17. PubMed ID: 22569194
[TBL] [Abstract][Full Text] [Related]
19. No parkinsonism in SCA2 and SCA3 despite severe neurodegeneration of the dopaminergic substantia nigra.
Schöls L; Reimold M; Seidel K; Globas C; Brockmann K; Hauser TK; Auburger G; Bürk K; den Dunnen W; Reischl G; Korf HW; Brunt ER; Rüb U
Brain; 2015 Nov; 138(Pt 11):3316-26. PubMed ID: 26362908
[TBL] [Abstract][Full Text] [Related]
20. Clinical markers for identifying cholinergic deficits in Parkinson's disease.
Müller ML; Bohnen NI; Kotagal V; Scott PJ; Koeppe RA; Frey KA; Albin RL
Mov Disord; 2015 Feb; 30(2):269-73. PubMed ID: 25393613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
